563 related articles for article (PubMed ID: 29302228)
1. Cannabis, cannabinoids, and health.
Lafaye G; Karila L; Blecha L; Benyamina A
Dialogues Clin Neurosci; 2017 Sep; 19(3):309-316. PubMed ID: 29302228
[TBL] [Abstract][Full Text] [Related]
2. The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects.
van Amsterdam J; Brunt T; van den Brink W
J Psychopharmacol; 2015 Mar; 29(3):254-63. PubMed ID: 25586398
[TBL] [Abstract][Full Text] [Related]
3. [Cannabis use and somatic consequences].
Franchitto N
Rev Prat; 2020 Jan; 70(1):69-77. PubMed ID: 32877036
[TBL] [Abstract][Full Text] [Related]
4. Psychosis and synthetic cannabinoids.
Deng H; Verrico CD; Kosten TR; Nielsen DA
Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
[TBL] [Abstract][Full Text] [Related]
5. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
[TBL] [Abstract][Full Text] [Related]
6. [Cannabis and cannabinoids as drugs].
Khiabani HZ; Mørland J
Tidsskr Nor Laegeforen; 2007 Mar; 127(5):579-82. PubMed ID: 17332810
[TBL] [Abstract][Full Text] [Related]
7. Cannabis-associated psychosis: Neural substrate and clinical impact.
Murray RM; Englund A; Abi-Dargham A; Lewis DA; Di Forti M; Davies C; Sherif M; McGuire P; D'Souza DC
Neuropharmacology; 2017 Sep; 124():89-104. PubMed ID: 28634109
[TBL] [Abstract][Full Text] [Related]
8. Cannabis and psychosis: what do we know and what should we do?
Colizzi M; Murray R
Br J Psychiatry; 2018 Apr; 212(4):195-196. PubMed ID: 29557759
[TBL] [Abstract][Full Text] [Related]
9. The Relevance of Sex in the Association of Synthetic Cannabinoid Use With Psychosis and Agitation in an Inpatient Population.
Bassir Nia A; Mann CL; Spriggs S; DeFrancisco DR; Carbonaro S; Parvez L; Galynker II; Perkel CA; Hurd YL
J Clin Psychiatry; 2019 Jul; 80(4):. PubMed ID: 31265768
[TBL] [Abstract][Full Text] [Related]
10. Current Cannabidiol Safety: A Review.
Singh C; Rao K; Yadav N; Vashist Y; Chugh P; Bansal N; Minocha N
Curr Drug Saf; 2023; 18(4):465-473. PubMed ID: 36056846
[TBL] [Abstract][Full Text] [Related]
11. A critical assessment of the abuse, dependence and associated safety risks of naturally occurring and synthetic cannabinoids.
Heal DJ; Gosden J; Smith SL
Front Psychiatry; 2024; 15():1322434. PubMed ID: 38915848
[TBL] [Abstract][Full Text] [Related]
12. Exposure to cannabinoids can lead to persistent cognitive and psychiatric disorders.
Krebs MO; Kebir O; Jay TM
Eur J Pain; 2019 Aug; 23(7):1225-1233. PubMed ID: 30793421
[TBL] [Abstract][Full Text] [Related]
13. Medical marijuana and the mind. More is known about the psychiatric risks than the benefits.
Harv Ment Health Lett; 2010 Apr; 26(10):1-3. PubMed ID: 20499454
[No Abstract] [Full Text] [Related]
14. Potency trends of cannabis in Jamaica during the period of 2014 to 2020.
Lindsay CM; Bernard KK; Hammond AM; Beckford S; Abel WD; Brown PD; Young LE
Drug Test Anal; 2024 Feb; 16(2):174-186. PubMed ID: 37309060
[TBL] [Abstract][Full Text] [Related]
15. Subjective and physiological effects of oromucosal sprays containing cannabinoids (nabiximols): potentials and limitations for psychosis research.
Schoedel KA; Harrison SJ
Curr Pharm Des; 2012; 18(32):5008-14. PubMed ID: 22716155
[TBL] [Abstract][Full Text] [Related]
16. Potency of delta 9-THC and other cannabinoids in cannabis in England in 2005: implications for psychoactivity and pharmacology.
Potter DJ; Clark P; Brown MB
J Forensic Sci; 2008 Jan; 53(1):90-4. PubMed ID: 18279244
[TBL] [Abstract][Full Text] [Related]
17. What is the mechanism whereby cannabis use increases risk of psychosis?
Luzi S; Morrison PD; Powell J; di Forti M; Murray RM
Neurotox Res; 2008 Oct; 14(2-3):105-12. PubMed ID: 19073418
[TBL] [Abstract][Full Text] [Related]
18. First episode psychosis with and without the use of cannabis and synthetic cannabinoids: Psychopathology, global functioning and suicidal ideation and antipsychotic effectiveness.
Ricci V; Ceci F; Di Carlo F; Di Muzio I; Ciavoni L; Santangelo M; Di Salvo G; Pettorruso M; Martinotti G; Maina G
Psychiatry Res; 2023 Feb; 320():115053. PubMed ID: 36682093
[TBL] [Abstract][Full Text] [Related]
19. Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z; Jubeh B; Bufo SA; Karaman R; Scrano L
Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33562446
[TBL] [Abstract][Full Text] [Related]
20. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
Deiana S
Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
